Market Overview

BZ NOTE: Wedbush's Dr. Liana Moussatos Has An Outperform Rating Of $6/Share, Mentions That There Is No Catalyst For Today's Move; Sees FY16 Potential

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for XOMA

DateFirmActionFromTo
Oct 2017H.C. WainwrightAssumesBuy
Sep 2017WedbushUpgradesNeutralOutperform
Jun 2017H.C. WainwrightInitiates Coverage OnBuy

View More Analyst Ratings for XOMA
View the Latest Analyst Ratings

Posted-In: Analyst Color Exclusives Analyst Ratings Movers

 

Related Articles (XOMA)